Eyes on September 2026: ESCRS insights, gene therapy wins, and the push to treat myopia as a disease

ESCRS 2026 brought thousands of anterior segment specialists to London, EyeCon 2026 put optometrists and ophthalmologists at the same table, and a steady stream of trial readouts and regulatory decisions kept the pipeline moving. Here is what our editors and contributors covered.